Campbell AJ

Al Yazidi LS

Phuong LK

Leung C

Best EJ

Webb RH

Voss L

Athan E

Britton PN

Bryant PA

Butters CT

Carapetis JR

Ching NS

Coombs GW

Daley D

Francis JR

Hung TY

Mowlaboccus S

Nourse C

Ojaimi S

Tai A

Vasilunas N

McMullan B

Blyth CC

Bowen AC

2021-06-05

BACKGROUND: Staphylococcus aureus is a common cause of bacteremia, yet the epidemiology, and predictors of poor outcome remain inadequately defined in childhood. METHODS: ISAIAH is a prospective, cross-sectional study of S. aureus bacteremia (SAB), in children hospitalized in Australia and New Zealand, over 24-months (2017-2018). RESULTS: Overall, 552 SABs were identified, (incidence 4.4/100,000/yr [95% confidence interval (CI) 2.2-8.8]), with methicillin-susceptible (84%), community onset (78%) infection predominating. Indigenous children (8.1/100,000/yr [CI 4.8-14.4]), those from lower-socioeconomic areas (5.5/100,000/yr [CI 2.8-10.2]) and neonates (6.6/100,000/yr (CI 3.4-11.7) were over-represented. Although 90-day mortality was infrequent, one-third experienced the composite of: length of stay >30 days (26%), ICU admission (20%), relapse (4%), or death (3%).Predictors of mortality included prematurity (aOR 16.8 [CI 1.6-296.9]), multifocal infection (aOR 22.6 [CI 1.4-498.5]), necrotizing pneumonia (aOR 38.9 [CI 1.7 - 1754.6]), multiorgan dysfunction (aOR 26.5 [CI 4.1-268.8]) and empiric-vancomycin (aOR 15.7 [CI 1.6-434.4]); whilst Infectious Diseases (ID) consultation (aOR 0.07 [CI 0.004-0.9]) was protective. Neither MRSA nor vancomycin trough-targets impacted survival; however, empiric-vancomycin was associated with significant nephrotoxicity (OR 3.1 [CI 1.3-8.1]). CONCLUSIONS: High SAB incidence was demonstrated, with at-risk populations identified for future prioritized care. For the first time in a pediatric setting, necrotizing pneumonia and multifocal infection were predictors of mortality, whilst ID consultation was protective. The need to re-evaluate pediatric vancomycin trough-targets and limit unnecessary empiric-vancomycin exposure, to reduce poor outcomes and nephrotoxicity is highlighted. One in three children experienced considerable SAB morbidity, therefore pediatric inclusion in future SAB comparator trials is paramount to improve outcomes.

Department of Infectious Diseases, Perth Children's Hospital, Perth, Australia.

Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Australia.

School of Medicine, University of Western Australia, Perth, Australia.

Child Health Department, Sultan Qaboos University Hospital, Muscat, Oman.

Department of Immunology and Infectious Diseases, Sydney Children's Hospital, Randwick, Sydney, Australia.

The Children's Department of Infectious Diseases and Microbiology, the Children's Hospital at Westmead, NSW, Australia.

Department of General Medicine, Infectious Diseases Unit, Royal Children's Hospital, Melbourne, Australia.

Infection and Immunity Group, Murdoch Children's Research Institute, Melbourne, Australia.

Department of Paediatrics, Wagga Wagga Base Hospital, New South Wales, Australia.

Department of Paediatrics; Child and Youth Health, The University of Auckland.

The National Immunisation Advisory Centre, The University of Auckland.

Department of Infectious Diseases, Starship Children's Hospital, Auckland, New Zealand.

Department of Paediatrics, Kidz First Hospital, Auckland, New Zealand.

Department of Infectious Disease, Barwon Health, Geelong, Australia.

School of Medicine, Deakin University, Geelong, Australia.

Sydney Medical School and Marie Bashir Institute, University of Sydney, NSW, Australia.

Department of Infectious Diseases and Microbiology, the Children's Hospital at Westmead, Sydney, Australia.

Infectious Diseases Unit, Department of General Medicine, The Royal Children's Hospital, Parkville, Victoria, Australia.

Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, Victoria, Australia.

Infectious Diseases Unit, The Royal Children's Hospital, Melbourne, Victoria, Australia.

Department of Infectious Diseases, Perth Children's Hospital, Nedlands, Western Australia.

Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia.

University of Western Australia. School of Medicine, Perth, Western, Australia.

Department of General Paediatrics, Monash Children's Hospital, Monash Health, Victoria, Australia.

Department of Paediatrics, Monash University, Clayton, Australia.

Department of Microbiology, PathWest Laboratory Medicine, QEII Medical Centre, Royal Perth Hospital and Fiona Stanley Hospital, Western Australia.

Antimicrobial Resistance and Infectious Diseases Research (AMRID) Laboratory, Murdoch University, Perth, Western Australia.

The Australian Group on Antimicrobial Resistance (AGAR).

Department of Paediatrics, Royal Darwin Hospital, Darwin, Australia.

Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia.

Doherty Institute of Infection and Immunity, The Royal Melbourne Hospital, The University of Melbourne.

College of Science, Health, Engineering and Education, Murdoch University, Murdoch.

School of Biomedical Sciences, University of Western Australia, Nedlands.

Queensland Children's Hospital, Brisbane, Australia.

Faculty of Medicine, University of Queensland, Australia.

Infection & Immunity, Monash Children's Hospital, Monash Health, Clayton, Victoria, Australia.

Department of Pediatrics, Monash University, Clayton, Australia.

Infectious Diseases Department, Women's and Children's Hospital, Adelaide.

School of Women's and Children's Health, University of New South Wales, Sydney, Australia.

National Centre for Infections in Cancer, University of Melbourne, Melbourne, Australia.

Department of Infectious Diseases, Perth Children's Hospital, Nedlands.

Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute and School of Medicine, University of Western Australia.

Department of Microbiology, PathWest Laboratory Medicine, QEII Medical Centre, Perth, Western Australia.

Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute.

School of Medicine, University of Western Australia, Subiaco.

Menzies School of Health Research, Charles Darwin Hospital, Darwin, NT.

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Clin Infect Dis. 2021 Jun 5:ciab510. doi: 10.1093/cid/ciab510.

https://pubmed.ncbi.nlm.nih.gov/34089594/?otool=iaurydwlib

https://hdl.handle.net/10137/11792

Pediatric Staphylococcus aureus bacteremia: clinical spectrum and predictors of poor outcome.

Journal Article

Publication